Carthera
PrivateLast Round
Series B
Extension
Dec 11, 2023
Total Funding Raised
$102.54M
Company Overview
Carthera is a medtech company that develops ultrasound-based medical devices designed to treat brain disorders through intracranial implants and microbubble agents that enhance drug delivery to the brain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carthera Comparables
Compare Carthera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OxSonics Therapeutics | 79% | |
| TheraSonic | 78% | |
| NaviFUS Corp. | 77% | |
Carthera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 11, 2023 | ||||
| Series B | Jun 27, 2023 | ||||
| Grant | Sep 14, 2020 | ||||
| Series B | Dec 12, 2018 | ||||
| Grant | Oct 1, 2016 | ||||
Series A | Jul 8, 2015 |
Key People
Founding team and executive leadership
Carthera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, Series B |
| Unorthodox Ventures | Series B, Series B Extension |
| Supernova Invest | Series B, Seed, Series B Extension |
| Panakès Partners | Series B, Series A |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 27, 2023
$40M round led by European Innovation Council and Relyens.
- Sep 14, 2020
$2.3M grant received from the European Innovation Council Fund.
Carthera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Carthera's valuation, stock price, and market status.